Advertisment

DCGI gives nod for conducting study on mixing Covaxin and Covishield

author-image
Rajan Nath
New Update
DCGI gives nod for conducting study on mixing Covaxin and Covishield
Advertisment
In a major development, the Drugs Controller General of India (DCGI) on Wednesday gave a nod for conducting a study on mixing Covid-19 vaccines 'Covaxin and Covishield'. During a press briefing on Tuesday, Dr. VK Paul, Niti Aayog, had said that permission has been granted for a research study by CMC Vellore (Tamil Nadu) on mixing of Covid-19 vaccines doses — Covaxin and Covishield.
Advertisment
Also Read | Tokyo Olympics 2020: List of medal winners, historic golden throw by Neeraj Chopra, India’s record-breaking journey Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates:  Report Earlier, the Indian Council of Medical Research (ICMR) had revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the Covid-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogenicity results. Also Read | Tokyo Olympics 2020: Meet unsung heroes behind the success of India’s medal winners
Advertisment
Coronavirus Vaccine Recipients Will Not Get To Choose From Covishield  Covaxin For Now: Centre The nationwide vaccination program had entered into 4th month when the event of mixed dosing raised considerable anxiety in the public domain with the potential to contributing to vaccine hesitancy. ICMR conducted the current investigation against that backdrop. In the study, ICMR compared the safety and immunogenicity profile with those individuals who received either Covaxin or Covishield and it showed better results. Little room for judicial interference': Centre defends Covid-19 vaccine  pricing policy in Supreme Court | India News – India TV The study conducted on individuals in the northern state of Uttar Pradesh in India received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks. -PTC News-
covid-19 coronavirus-india covid-19-vaccine covaxin covishield covishield-vaccine covaxin-vaccine
Advertisment

Stay updated with the latest news headlines.

Follow us:
Advertisment